# Akebia Therapeutics, Inc.: Form 8-K, filed Apr 23, 2024

- Company: [Akebia Therapeutics, Inc.](/companies/akba.md) (CIK 1517022)
- Form: 8-K
- Filed: 2024-04-23
- Accepted by EDGAR: Apr 23, 2024, 08:32 ET
- Period: 2024-04-17
- Accession: 0001517022-24-000035
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1517022/000151702224000035/akba-20242304xkreosdrawdown.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1517022/000151702224000035/

## Items reported

- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1517022/000151702224000035/akba-20242304xkreosdrawdown.htm

Filed Apr 23, 2024.
Source: SEC EDGAR, the filing index for accession 0001517022-24-000035. Last ingested by Listed: Nov 5, 2026, 12:07 ET. No prices; not investment advice.
